International Journal of Medical and Pharmaceutical Research
2025, Volume-6, Issue 6 : 2341-2356
Research Article
Development and Validation of an HPTLC Method as per ICH Guidelines Followed by GC-MS Characterization of Lupeol from Arisaema tortuosum (Wall.) Schott
 ,
 ,
Received
Sept. 25, 2025
Accepted
Nov. 15, 2025
Published
Dec. 6, 2025
Abstract

Arisaema tortuosum (Wall.) Schott holds significant ethnomedicinal value, yet its phytochemical profile has remained scientifically underexplored. This study provides a comprehensive analysis of its tuber extracts, revealing substantial solvent-dependent variations in composition. Extraction through maceration yielded 2.5% (chloroform), 2.9% (ethyl acetate), 6.3% (ethanol), and 11.2% (aqueous) w/w of crude extract. Phytochemical screening demonstrated the presence of alkaloids, flavonoids, phenols, and tannins across various extracts. Quantitative analysis established the ethanol extract as superior, containing the highest total phenolic (0.878 mg GAE/100 mg) and flavonoid (0.805 mg QE/100 mg) content.

A novel HPTLC method for lupeol quantification was developed and validated per ICH guidelines, showing excellent linearity (R² = 0.999) across 50-175 ng/spot. The method demonstrated high precision (intra-day %RSD 0.04-0.09, inter-day %RSD 1.60-1.75) and accuracy (recovery 99.92-100.05%), with LOD and LOQ of 1.22 and 3.70 ng/spot respectively. Lupeol was identified at Rf 0.67 and quantified highest in ethanol extract (0.067% w/w), followed by chloroform (0.055%) and ethyl acetate (0.052%) extracts. GCMS analysis confirmed lupeol identity through matching retention times (sample: 31.85 min, standard: 31.86 min) and characteristic molecular ion (m/z 426).

This study validates A. tortuosum as a rich source of bioactive compounds. The ethanol extract emerges as a particularly promising candidate for further drug development. These findings successfully bridge traditional knowledge with scientific validation, advocating for deeper exploration of its phytochemical mechanisms. The proposed HPTLC method provides a dependable tool for quality control and standardization of this vital medicinal plant.

Keywords
INTRODUCTION
Recommended Articles
Research Article Open Access
In Silico Molecular Docking, Structural Confidence and ADMET Evaluation of Novel Spiro Derivatives against FKT3 Kinase Inhibitor
2026, Volume-7, Issue 4 : 3232-3236
Research Article Open Access
Association of ABO and Rhesus Blood Types with Transfusion-Transmitted Infections among Blood Donors at a Tertiary Care Centre in Northern India: A Retrospective Cross-Sectional Study
2026, Volume-7, Issue 4 : 3210-3216
Research Article Open Access
Maternal and Neonatal Outcome of Early Onset Preeclampsia with or Without Systemic Lupus Erythematosus (SLE): An Ambispective Study
2026, Volume-7, Issue 4 : 3189-3192
Case Report Open Access
Redefining Cheek Plumper Prosthesis: A Novel Hollow Lightweight Design Using Vacuum-Formed Thermoplastic Sheet – A Case Report
2026, Volume-7, Issue 4 : 3223-3231
International Journal of Medical and Pharmaceutical Research journal thumbnail
Volume-6, Issue 6
Citations
151 Views
214 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
facebook twitter linkedin mendeley research-gate
© Copyright | International Journal of Medical and Pharmaceutical Research | All Rights Reserved